As of 23 Sept 2026, Vijaya Diagnostic Centre Ltd share price is ₹1,514.90. The stock opened at ₹1,514.90 and had closed at ₹1,557.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹847.90 and a high of ₹1,576.90. In terms of performance, Vijaya Diagnostic Centre Ltd share price has increased by 70.37% over the past six months and has increased by 43.91% over the last year.
VIJAYA Stock Price Chart
Vijaya Diagnostic Centre Ltd Overview
About VIJAYA
Vijaya Diagnostic Centre is engaged in the business of providing comprehensive range of diagnostic services, spanning pathological investigations, basic and high end radiology, nuclear medicine and related healthcare services.
Vijaya Diagnostic Centre Ltd Historical Performance
Vijaya Diagnostic Centre Ltd Fundamentals
Vijaya Diagnostic Centre Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 793.03 | 652.52 | 546.46 | 464.15 | 463.80 |
| EBITDA | 349.14 | 272.17 | 231.59 | 193.54 | 212.78 |
| Net Profit | 179.28 | 135.93 | 114.60 | 83.23 | 108.10 |
| EPS | 17.43 | 13.23 | 11.21 | 8.16 | 10.60 |
Vijaya Diagnostic Centre Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,544.55 |
| Resistance 1 (R1) | 1,572.10 |
| Pivot Point | 1,558.85 |
Vijaya Diagnostic Centre Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 16-Sep-2026 | 07-May-2026 | 16-Sep-2026 | Final | ₹2.00 |
| 29-Aug-2025 | 12-May-2025 | 29-Aug-2025 | Final | ₹2.00 |
| 30-Aug-2024 | 08-May-2024 | 30-Aug-2024 | Final | ₹1.00 |
| 13-Sep-2023 | 29-May-2023 | 13-Sep-2023 | Final | ₹1.00 |
| 20-Sep-2022 | 26-May-2022 | 21-Sep-2022 | Final | ₹1.00 |
VIJAYA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Sura Surendranath Reddy | Chairman |
| Sura Suprita Reddy | Managing Director & Chief Executive Officer |
| Sunil Chandra Kondapally | E D & Wholetime Directorector |
Vijaya Diagnostic Centre Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,835.50-0.86% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,056.50-0.95% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹896.55+0.34% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Vijaya Diagnostic Centre Ltd today is ₹1,514.90 on NSE and ₹1,514.90 on BSE.
- The 52-week high of Vijaya Diagnostic Centre Ltd is ₹1,576.90, while the 52-week low is ₹847.90.
- The current market capitalisation of Vijaya Diagnostic Centre Ltd is approximately ₹15,603 crore.
- The P/E (Price-to-Earnings) ratio of Vijaya Diagnostic Centre Ltd is 60.43. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Vijaya Diagnostic Centre Ltd is 11.17. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Vijaya Diagnostic Centre Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for VIJAYA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Vijaya Diagnostic Centre Ltd has delivered a return of approximately 233.20%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Vijaya Diagnostic Centre Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 52.51% promoters, -19.00% FIIs, 31.61% DIIs, and 3.49% public shareholders.

